New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Amgen Inc.
AMGN
Shape
US Flag

NASDAQ

160B

Drug Manufacturers - General

Next Earning date - 01 May 2025

160B

Drug Manufacturers - General

Next Earning date - 01 May 2025

289.02USD

Shape0.15 ( 0.05%)
Market Closed (as of Feb 04, 21:00 EDT)
favorite-chart

Relative Strenght

27
favorite-chart

Volume Buzz

-21%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

17%

Quote Panel

Shape
Updated February 7, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

AMGN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$35B

Shape284%

2025-Revenue

$20.68

Shape1668%

2025-EPS

$18B

Shape660%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

392.50(31.81%)

Number of analyst

2

Last analyst upgrade/downgrade

Citigroup

initialise

Previous: Not converted

2024-11-13

Now: Neutral

Bernstein

initialise

Previous: Not converted

2024-10-17

Now: Outperform

Cantor Fitzgerald

initialise

Previous: Not converted

2024-09-27

Now: Overweight

Wells Fargo

downgrade

Previous: Overweight

2024-08-07

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-6%

3.98
vs 4.25

Q2.23

arrow
arrow

+8%

5
vs 4.65

Q3.23

arrow
arrow

+6%

4.96
vs 4.7

Q4.23

arrow
arrow

+15%

4.71
vs 4.09

Q1.24

arrow
arrow

0%

3.96
vs 3.98

Q2.24

arrow
arrow

-1%

4.97
vs 5

Q3.24

arrow
arrow

+13%

5.58
vs 4.96

Q4.24

arrow
arrow

+13%

5.31
vs 4.71

Q1.25

arrow
arrow

+9%

4.3
vs 3.96

Q2.25

arrow
arrow

+8%

5.37
vs 4.97

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-2%

6.1B  vs 6.2B

Q2.23

arrow
arrow

+6%

7B  vs 6.6B

Q3.23

arrow
arrow

+4%

6.9B  vs 6.7B

Q4.23

arrow
arrow

+20%

8.2B  vs 6.8B

Q1.24

arrow
arrow

+21%

7.4B  vs 6.1B

Q2.24

arrow
arrow

+19%

8.3B  vs 7B

Q3.24

arrow
arrow

+23%

8.5B  vs 6.9B

Q4.24

arrow
arrow

+11%

9.1B  vs 8.2B

Q1.25

arrow
arrow

+10%

8.1B  vs 7.4B

Q2.25

arrow
arrow

+7%

8.9B  vs 8.3B

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+53%

0.53
vs 0.44

Q2.23

arrow
arrow

+20%

0.2
vs 0.53

Q3.23

arrow
arrow

+23%

0.23
vs 0.2

Q4.23

arrow
arrow

+12%

0.12
vs 0.23

Q1.24

arrow
arrow

-2%

-0.02
vs 0.12

Q2.24

arrow
arrow

+13%

0.13
vs -0.02

Q3.24

arrow
arrow

+38%

0.38
vs 0.13

Q4.24

arrow
arrow

+11%

0.11
vs 0.38

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

2560

2.6K
vs 2.4K

8%

Q1.23

arrow
arrow

2491

2.5K
vs 2.6K

-3%

Q2.23

arrow
arrow

2446

2.4K
vs 2.5K

-2%

Q3.23

arrow
arrow

2567

2.6K
vs 2.4K

5%

Q4.23

arrow
arrow

2787

2.8K
vs 2.6K

9%

Q1.24

arrow
arrow

2777

2.8K
vs 2.8K

0%

Q2.24

arrow
arrow

2856

2.9K
vs 2.8K

3%

Q3.24

arrow
arrow

2886

2.9K
vs 2.9K

1%

Earnings Growth

Latest News